Press Releases | Medtronic

Month Year

Email alerts

May 4, 2016

HeartWare International Reports First Quarter 2016 Financial Results

-- First quarter 2016 revenue of $55 million reflects lower year-over-year clinical trial revenue and competitive dynamics --

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
May 4, 2016

Medtronic Welcomes Karen L. Parkhill as Its New Chief Financial Officer

Gary Ellis to Remain on Medtronic Executive Committee Until Retirement in Fiscal Year 2017

DUBLIN - May 4, 2016 - Medtronic plc (NYSE: MDT) announced today the appointment of Karen L. Parkhill as executive vice president and chief financial officer (CFO), effective June 20, 2016....
May 3, 2016

Late-Breaking Study Provides Evidence to Support Beneficial Seven-Year Clinical Outcomes and Patient Satisfaction for 2-Level Prestige LP(TM) Cervical Disc Patients

Study Represents Longest Patient Follow-Up Data for U.S. 2-Level Cervical Disc Patients

DUBLIN and CHICAGO - May 3, 2016 - Medtronic plc (NYSE: MDT) today announced results of seven-year follow-up data demonstrating favorable clinical outcomes and patient satisfaction for the 2-level...
May 2, 2016

Medtronic Receives FDA Approval for New Single-Chamber ICDs That Detect Atrial Fibrillation

Visia AF MRI(TM) SureScan® and Visia AF(TM)ICDs Treat Dangerous Heart Rhythms and Enable Physicians to Identify Patients at Increased Risk for Stroke and Heart Failure Due to AF

DUBLIN - May 2, 2016 - Medtronic plc (NYSE: MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval for the Visia AF MRI(TM) SureScan® and Visia AF(TM)...
May 2, 2016

Medtronic Expands MRI-Compatible Portfolio with FDA Clearance of StrataMR(TM) Shunt System

Patients with Hydrocephalus and CSF Disorders Have Greater Access to Full Body MRI Scans with StrataMR

DUBLIN - May 2, 2016 - Medtronic plc (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) clearance of StrataMR(TM) valves and shunts, an addition to Medtronic's family of...
May 1, 2016

Medtronic Receives Expanded Indication From FDA for Pillcam(TM) Colon 2 Capsule

Potentially Reaching More Patients at Risk for Colon Cancer

DUBLIN - March 31, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) cleared PillCam(TM) COLON 2 capsule for an expanded indication for use. The...
Apr 30, 2016

Medtronic CoreValve® System Maintains Survival Advantages Over Surgery in High Risk Aortic Stenosis Patients at Three Years

New Data at ACC.16 First to Show Superior, Longer-Term Outcomes for Self-Expanding TAVR vs. SAVR at Three Years Results Published Simultaneously in the Journal of American College of Cardiology (JACC)

DUBLIN and CHICAGO - April 3, 2016 - Medtronic plc (NYSE: MDT) today announced new data from the High Risk Study of the CoreValve U.S. Pivotal Trial that show superior clinical outcomes for...
Apr 27, 2016

Medtronic Demonstrates Commitment to EVAR in Comparison Study of ENGAGE Global Registry and Landmark EVAR 1 Trial

Clinical Integrity on Display through Longest Term Data of 1,200 Endurant AAA Stent Graft Patients

DUBLIN AND LONDON - April 27, 2016 - Medtronic plc (NYSE:MDT) today reported on the ENGAGE global registry of experiences with the Endurant® AAA stent graft system from Medtronic with a reference...
Apr 27, 2016

HeartWare Completes Enrollment In HVAD® System LATERAL Study™

- Clinical Trial Evaluates Less-Invasive Thoracotomy Implant Technique of the HVAD System in Patients with Advanced Heart Failure -

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
Apr 26, 2016

Medtronic IN.PACT Admiral DCB Maintains Durable, Consistent and Safe Outcomes in Challenging Peripheral Cases

New Rigorous Analyses Presented at Charing Cross Reinforce Efficacy in Females, Chronic Total Occlusions and Patients with Diabetes; Data Details Unique, Sustained Benefit with IN.PACT Admiral DCB

DUBLIN and LONDON - April 26, 2016 - Medtronic plc (NYSE: MDT) today added to its robust body of clinical evidence supporting the IN.PACTTM AdmiralTM drug-coated balloon (DCB) with several new...

Show per page